By Counterforce Health Team in Lumizyme (alglucosidase alfa) —

How to Get Lumizyme (alglucosidase alfa) Covered by Aetna (CVS Health) in Georgia: Complete Authorization Guide

Quick Answer: Getting Lumizyme Covered by Aetna in Georgia

Aetna requires prior authorization for Lumizyme (alglucosidase alfa) with confirmed Pompe disease diagnosis and specialist prescriber. Submit the Aetna Lumizyme Precertification Form with enzyme assay or genetic testing results. If denied, you have 60 days to request external review through the Georgia Department of Insurance. CVS Specialty typically handles dispensing and infusion coordination.

First step today: Verify your diagnosis documentation and contact your metabolic specialist to initiate the Aetna prior authorization process.

Table of Contents

When Alternatives Make Sense

Aetna is moving Lumizyme to non-preferred status in 2025, meaning they'll likely require trying other Pompe disease treatments first. This step therapy approach makes clinical sense in some situations but not others.

Alternatives may be appropriate when:

  • You're newly diagnosed and haven't started any enzyme replacement therapy
  • You've experienced significant infusion reactions with Lumizyme
  • Your current therapy isn't providing adequate disease stabilization
  • Laboratory tests show anti-drug antibodies affecting Lumizyme effectiveness

Alternatives are typically NOT appropriate when:

  • You're stable on current Lumizyme therapy
  • You've previously failed or had adverse reactions to newer treatments
  • You have specific contraindications to alternative therapies
  • Switching would create clinical instability or gaps in treatment
Note: Georgia Medicaid and PeachCare also cover Pompe disease treatments through their managed care plans, with similar prior authorization requirements but potentially different formulary preferences.

Typical Alternatives to Lumizyme

Nexviazyme (avalglucosidase alfa)

What it is: Second-generation enzyme replacement therapy with enhanced cellular uptake Access considerations: Often preferred by insurers as first-line therapy Clinical advantage: Superior efficacy in clinical trials - patients were 2.37 times more likely to benefit compared to Lumizyme Monitoring: Similar to Lumizyme - pulmonary function, motor assessments, cardiac monitoring

Pombiliti + Opfolda Combination

What it is: Newer ERT (cipaglucosidase alfa) plus oral chaperone therapy (miglustat) Access considerations: Also moving to non-preferred status on Aetna in 2025 Clinical advantage: Designed for enhanced enzyme stability and cellular delivery Monitoring: More complex regimen requiring coordination of IV and oral medications

Clinician Corner: When documenting medical necessity for any Pompe ERT, include baseline respiratory function (FVC), motor function assessments, cardiac status (LVMI if applicable), and clear treatment goals. Reference FDA labeling and current Pompe disease management guidelines.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Must get approval before treatment Aetna Precert List Aetna Policy
Confirmed Diagnosis Enzyme assay or genetic testing required Clinical Policy Bulletin 0442 Aetna Medical Policy
Specialist Prescriber Metabolic or lysosomal storage disorder specialist Lumizyme Precert Form Aetna Requirements
CVS Specialty Dispensing Must use designated specialty pharmacy CVS Specialty Network Requirement
Site of Care Justification Hospital vs. office vs. home infusion Drug Infusion Policy Utilization Management

Step-by-Step: Fastest Path to Approval

1. Gather Required Documentation (Patient/Family)

What you need:

  • Insurance card with member ID
  • Confirmed Pompe disease diagnosis (enzyme assay or genetic testing results)
  • Complete medical records from your metabolic specialist
  • List of any previous treatments tried and their outcomes

2. Specialist Consultation and Assessment (Clinician)

Timeline: Schedule within 1-2 weeks Documents needed:

  • Current pulmonary function tests (FVC)
  • Motor function assessments (6-minute walk test if applicable)
  • Cardiac evaluation (echo or MRI with LVMI)
  • Weight-based dosing calculations (20 mg/kg every 2 weeks)

3. Complete Aetna Prior Authorization (Clinician)

How to submit: Aetna Lumizyme Precertification Form Timeline: Submit within 3-5 business days of consultation Key sections to complete:

  • Section G: Clinical Information (all fields required)
  • Site of care justification if requesting hospital-based infusion
  • Attestation of confirmed Pompe disease diagnosis

4. CVS Specialty Enrollment (Clinician)

Form needed: CVS Lysosomal Storage Enrollment Form Contact: 1-800-237-2767 for coordination Timeline: Process within 2 business days once PA is approved

5. Infusion Coordination (Patient/Clinician)

For home infusion: Contact Coram at 1-866-899-1661 For clinic infusion: Verify in-network status and scheduling Timeline: Schedule first infusion within 1 week of drug availability

6. Monitor and Document Response (Ongoing)

Frequency: Every 6 months for renewals Measurements: FVC trends, motor function, cardiac status, adverse events Documentation: Objective evidence of improvement or stabilization

Exception Strategy: When to Push for Lumizyme

Strong Clinical Arguments for Lumizyme Over Alternatives

Previous Treatment Failure:

  • Document specific adverse reactions to Nexviazyme or Pombiliti
  • Include dates, symptoms, interventions attempted, and outcomes
  • Provide specialist notes confirming intolerance or contraindications

Clinical Stability on Current Therapy:

  • For existing Lumizyme patients, emphasize stable disease course
  • Include serial pulmonary function tests showing stabilization
  • Document absence of disease progression markers

Switching Risks:

  • Highlight potential for clinical deterioration during therapy transitions
  • Reference patient-specific factors (antibody status, comorbidities)
  • Include specialist recommendation against switching
From Our Advocates: One Georgia family successfully appealed an initial Nexviazyme requirement by providing detailed documentation of their child's 18-month stability on Lumizyme, including improved school attendance and maintained respiratory function. The key was showing objective measures of benefit that might be lost with switching.

Supporting Evidence to Include

Clinical Guidelines:

  • Reference current Pompe disease management recommendations
  • Include FDA labeling information supporting your specific clinical scenario
  • Cite peer-reviewed literature on switching risks or benefits

Functional Assessments:

  • Baseline and serial pulmonary function tests
  • Motor function evaluations and mobility assessments
  • Quality of life measures and functional independence scales

Switching Logistics and Coordination

When Counterforce Health helps families navigate insurance approvals for complex therapies like Pompe disease treatments, we often see the most success when switching logistics are carefully planned to avoid treatment gaps.

Pre-Switch Planning

Insurance Coordination:

  • Submit new prior authorization for alternative therapy 4-6 weeks before intended switch
  • Verify CVS Specialty can dispense the new medication
  • Confirm infusion site capabilities for the new therapy

Clinical Preparation:

  • Schedule baseline assessments before switching (FVC, motor function, cardiac)
  • Plan appropriate washout period if clinically indicated
  • Prepare infusion reaction management protocols for new therapy

Patient/Family Readiness:

  • Educate about potential differences in infusion time, premedications, or side effects
  • Coordinate work/school schedules for potentially different infusion requirements
  • Ensure home infusion nursing is trained on new therapy if applicable

During the Transition

Monitoring Requirements:

  • Increased clinical surveillance during first 2-3 infusions
  • Document any changes in symptoms, function, or quality of life
  • Track biomarkers if available (CK, hex4, liver enzymes)

Communication:

  • Regular check-ins with metabolic specialist
  • Prompt reporting of any concerning symptoms
  • Coordination between CVS Specialty and infusion providers

Appeals Process in Georgia

If your initial prior authorization is denied, Georgia provides strong consumer protections for insurance appeals.

Internal Appeal (Required First Step)

Timeline: Must file within timeframe specified in denial letter (typically 60-180 days) Process: Submit additional clinical documentation and specialist letter Decision timeline: 30-45 days for standard review, 72 hours for expedited

Georgia External Review

Eligibility: Available after internal appeal denial or concurrent with expedited internal appeal for urgent situations Timeline: Must file within 60 days of final internal denial letter Cost: Free to consumers Process: Submit application to Georgia Office of Commissioner of Insurance and Fire Safety Decision timeline: 30 business days for standard, 72 hours for expedited

Contact Information:

  • Consumer Services: 1-800-656-2298
  • Online complaint form available at Georgia DOI website
Tip: Georgia's external review is binding on insurers. Independent physicians in the same specialty review your case, and if they determine the treatment is medically necessary, Aetna must cover it.

Additional Support Resources

Georgians for a Healthy Future: Provides consumer assistance with insurance appeals Georgia Legal Services Program: Can assist with Medicaid/PeachCare appeals

Re-trying for Lumizyme Later

When Alternative Therapy Doesn't Work

Document Treatment Failure:

  • Objective measures showing decline or lack of improvement
  • Specific adverse events or intolerance issues
  • Functional assessments demonstrating inadequate response

Timeline Considerations:

  • Allow adequate trial period (typically 6-12 months unless safety concerns)
  • Document baseline and serial assessments throughout alternative therapy
  • Maintain regular specialist follow-up

Building Your Case for Lumizyme

Clinical Evidence:

  • Comparison data showing superior response to Lumizyme historically
  • Specialist letter recommending return to Lumizyme
  • Updated medical necessity documentation

Administrative Steps:

  • Submit new prior authorization with complete treatment history
  • Include all documentation from alternative therapy trial
  • Request expedited review if clinical deterioration is evident

Common Denial Reasons & Solutions

Denial Reason How to Overturn
"Not medically necessary" Submit enzyme assay/genetic testing, specialist consultation notes, functional assessments
"Experimental/investigational" Provide FDA approval information, current labeling, clinical guidelines
"Step therapy required" Document contraindications to preferred alternatives, prior failures, or switching risks
"Non-formulary drug" Request formulary exception with clinical justification and comparative effectiveness data
"Inappropriate site of care" Document medical necessity for hospital-based infusion (reactions, comorbidities, access issues)

FAQ

How long does Aetna prior authorization take in Georgia? Standard PA decisions typically take 14 days, expedited reviews within 72 hours. Submit complete documentation to avoid delays.

What if Lumizyme is non-formulary on my plan? You can request a formulary exception with clinical documentation showing medical necessity and why formulary alternatives aren't appropriate.

Can I request an expedited appeal in Georgia? Yes, for urgent medical situations. Both Aetna's internal process and Georgia's external review offer expedited timelines (typically 72 hours).

Does step therapy apply if I've been stable on Lumizyme? Existing patients often qualify for continuation of therapy exceptions. Document clinical stability and risks of switching.

What happens if CVS Specialty can't dispense my medication? Contact Aetna to request an out-of-network pharmacy exception if CVS Specialty cannot provide your specific medication or dosing requirements.

How do I coordinate home infusion through Coram? Your prescriber can refer you to Coram at 1-866-899-1661. They coordinate with CVS Specialty for drug delivery and nursing services.

What if my Georgia Medicaid plan denies coverage? Georgia Medicaid appeals go through the Department of Community Health's fair hearing process, not the insurance department. Contact your managed care plan first for internal appeal.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider and insurance company for specific coverage decisions. Counterforce Health helps patients and clinicians navigate insurance approvals for specialty medications through evidence-based appeals and targeted advocacy.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.